Should age alone be used as a criterion to limit the use of PTCA in elderly CAD patients?
Advanced age alone should not preclude the use of PTCA in patients with coronary artery disease.
While advanced age is associated with changes in risk and clinical parameters for CAD patients, age alone is not a reasonable criterion to limit the use of PTCA.
Forman et al. (Wed,) studied this question.